Your browser doesn't support javascript.
loading
OX40 Agonist Tumor Immunotherapy Does Not Impact Regulatory T Cell Suppressive Function.
Polesso, Fanny; Sarker, Minhaz; Weinberg, Andrew D; Murray, Susan E; Moran, Amy E.
Affiliation
  • Polesso F; Department of Cell, Developmental and Cancer Biology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239.
  • Sarker M; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239.
  • Weinberg AD; Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, OR 97213; and.
  • Murray SE; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239.
  • Moran AE; Biology Department, University of Portland, Portland, OR 97203.
J Immunol ; 203(7): 2011-2019, 2019 10 01.
Article in En | MEDLINE | ID: mdl-31434709
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes, Regulatory / CD8-Positive T-Lymphocytes / Receptors, OX40 / Immunotherapy / Antibodies, Neoplasm / Neoplasm Proteins / Neoplasms Limits: Animals Language: En Journal: J Immunol Year: 2019 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes, Regulatory / CD8-Positive T-Lymphocytes / Receptors, OX40 / Immunotherapy / Antibodies, Neoplasm / Neoplasm Proteins / Neoplasms Limits: Animals Language: En Journal: J Immunol Year: 2019 Document type: Article Country of publication: Estados Unidos